Literature DB >> 12970432

Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Yuanming Zhang1, John C Rassa, Maria Elena deObaldia, Lorraine M Albritton, Susan R Ross.   

Abstract

Mouse mammary tumor virus (MMTV) is a betaretrovirus that infects rodent cells and uses mouse transferrin receptor 1 for cell entry. To characterize the interaction of MMTV with its receptor, we aligned the MMTV envelope surface (SU) protein with that of Friend murine leukemia virus (F-MLV) and identified a putative receptor-binding domain (RBD) that included a receptor binding sequence (RBS) of five amino acids and a heparin-binding domain (HBD). Mutation of the HBD reduced virus infectivity, and soluble heparan sulfate blocked infection of cells by wild-type pseudovirus. Interestingly, some but not all MMTV-like elements found in primary and cultured human breast cancer cell lines, termed h-MTVs, had sequence alterations in the putative RBS. Single substitution of one of the amino acids found in an h-MTV RBS variant in the RBD of MMTV, Phe(40) to Ser, did not alter species tropism but abolished both virus binding to cells and infectivity. Neutralizing anti-SU monoclonal antibodies also recognized a glutathione S-transferase fusion protein that contained the five-amino-acid RBS region from MMTV. The critical Phe(40) residue is located on a surface of the MMTV RBD model that is distant from and may be structurally more rigid than the region of F-MLV RBD that contains its critical binding site residues. This suggests that, in contrast to other murine retroviruses, binding to its receptor may result in few or no changes in MMTV envelope protein conformation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970432      PMCID: PMC228533          DOI: 10.1128/jvi.77.19.10468-10478.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus.

Authors:  R A Davey; Y Zuo; J M Cunningham
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient.

Authors:  P Etkind; J Du; A Khan; J Pillitteri; P H Wiernik
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

3.  Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus.

Authors:  F J Kim; I Seiliez; C Denesvre; D Lavillette; F L Cosset; M Sitbon
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

4.  Expression of mouse mammary tumor virus envelope protein does not prevent superinfection in vivo or in vitro.

Authors:  J L Dzuris; W Zhu; D Kapkov; T V Golovkina; S R Ross
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

Review 5.  The transferrin receptor: role in health and disease.

Authors:  P Ponka; C N Lok
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

6.  Sequences homologous to the mouse mammary tumor virus env gene in human breast carcinoma correlate with overexpression of laminin receptor.

Authors:  B G Pogo; S M Melana; J F Holland; J F Mandeli; S Pilotti; P Casalini; S Ménard
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

Review 7.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

8.  A novel membrane protein is a mouse mammary tumor virus receptor.

Authors:  T V Golovkina; J Dzuris; B van den Hoogen; A B Jaffe; P C Wright; S M Cofer; S R Ross
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Syndecan captures, protects, and transmits HIV to T lymphocytes.

Authors:  Michael D Bobardt; Andrew C S Saphire; Hsiu-Cheng Hung; Xiaocong Yu; Bernadette Van der Schueren; Zhe Zhang; Guido David; Philippe A Gallay
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

10.  Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.

Authors:  Alexandra Purdy; Laure Case; Melody Duvall; Max Overstrom-Coleman; Nilah Monnier; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more
  26 in total

1.  An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.

Authors:  Susan R Ross; John W Schmidt; Elad Katz; Laura Cappelli; Stacy Hultine; Phyllis Gimotty; John G Monroe
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Spontaneous heteromerization of gammaretrovirus envelope proteins: a possible novel mechanism of retrovirus restriction.

Authors:  Marie Dewannieux; Mary K Collins
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

3.  APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions.

Authors:  Chioma M Okeoma; Alyssa L Huegel; Jaisri Lingappa; Michael D Feldman; Susan R Ross
Journal:  Cell Host Microbe       Date:  2010-12-16       Impact factor: 21.023

4.  Critical role of dendritic cells in mouse mammary tumor virus in vivo infection.

Authors:  Maria Cecilia Courreges; Dalia Burzyn; Irene Nepomnaschy; Isabel Piazzon; Susan R Ross
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Betaretroviral envelope subunits are noncovalently associated and restricted to the mammalian class.

Authors:  Jamie E Henzy; John M Coffin
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 6.  MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue.

Authors:  Susan R Ross
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

7.  Transferrin receptor binds virus capsid with dynamic motion.

Authors:  Hyunwook Lee; Heather M Callaway; Javier O Cifuente; Carol M Bator; Colin R Parrish; Susan L Hafenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

8.  APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.

Authors:  Alyssa L MacMillan; Rahul M Kohli; Susan R Ross
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

9.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

10.  Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.

Authors:  Rongcun Yang; Francisco Martinez Murillo; Hengmi Cui; Richard Blosser; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.